G. Hergenc Et Al. , "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.," CLINICAL CHEMISTRY , vol.45, no.11, pp.2050, 1999
Hergenc, G. Et Al. 1999. Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.. CLINICAL CHEMISTRY , vol.45, no.11 , 2050.
Hergenc, G., Ilcol, Y., Budak, Y., & Taga, Y., (1999). Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.. CLINICAL CHEMISTRY , vol.45, no.11, 2050.
Hergenc, G Et Al. "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.," CLINICAL CHEMISTRY , vol.45, no.11, 2050, 1999
Hergenc, G Et Al. "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.." CLINICAL CHEMISTRY , vol.45, no.11, pp.2050, 1999
Hergenc, G. Et Al. (1999) . "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.." CLINICAL CHEMISTRY , vol.45, no.11, p.2050.
@article{article, author={G Hergenc Et Al. }, title={Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.}, journal={CLINICAL CHEMISTRY}, year=1999, pages={2050} }